Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological studyShaobo Shi, Congxin Huang, Liangrong Zheng et al.|The Lancet Regional Health - Western Pacific|2022Cited by 137
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)Meng Chai, Yong‐Ming He, Zhao Wang et al.|BMC Medicine|2023Cited by 50
Prevalence and Risk of Atrial Fibrillation in China: A National Cross-Sectional Epidemiological StudyShaobo Shi, Congxin Huang, Yanhong Tang et al.|SSRN Electronic Journal|2021Cited by 38
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort StudyYaodong Li, Baopeng Tang, Yangxin Chen et al.|Medical Science Monitor|2023Cited by 0